Application form: drops and solutions for internal use
Indication group: expectorants, mucolytics
Active substance: Ambroxoli hydrochloridum 7,5mg v 1ml
minimum amount for dispatch: Ambroxol is expectorant with a mucolytic effect, causes an increased production of phlegm and at the same time dilutes phlegm, facilitates the movement of cilia and thus cleans the airways mucosa and increases its resistance against infection. Ambroxol is indicated for the treatment of acute and chronic diseases of airways connected with difficult expectoration, for the treatment of infectious diseases of airways, and acute and chronic inflammation of paranasal sinuses. It is possible to administer Ambroxol both to children and adults.
Manufacturer: Aliud Pharma GmbH and Co.KG, Laichingen, Germany, www.aliud.de